✦ LIBER ✦

Paclitaxel-Loaded Polymeric Micelle (230 mg/m2) and Cisplatin (60 mg/m2) vs. Paclitaxel (175 mg/m2) and Cisplatin (60 mg/m2) in Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase IIB Trial

✍ Scribed by Lee, Sung Yong; Park, Hee Sun; Lee, Kye Young; Kim, Hee Joung; Jeon, Young June; Jang, Tae Won; Lee, Kwan Ho; Kim, Young Chul; Kim, Kyu Sik; Oh, in Jae; Kim, Sun Young

Book ID: 118233152
Publisher: CIG Media Group, LP.
Year: 2013
Tongue: English
Weight: 390 KB
Volume: 14
Category: Article
ISSN: 1525-7304
DOI: 10.1016/j.cllc.2012.11.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter randomized trial of paclit

A multicenter randomized trial of paclitaxel (175 mg/m2) plus carboplatin (6AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6AUC) in advanced non-small cell lung cancer (NSCLC)

✍ P.A. Kosmidis; N. Mylonakis; D. Skarlos; E. Samantas; M.A. Demopoulos; C. Papadi 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 146 KB

A phase II trial of low-dose docetaxel (

A phase II trial of low-dose docetaxel (DCT) 60 mg/m2 in platinum-pretreated advanced non-small cell lung cancer (NSCLC)

✍ Kusaba, H; Nakamura, Y; Kunitoh, H; Sekine, I; Kubota, K; Tamura, T; Shinkai, T; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 120 KB

A randomised trial comparing chemotherap

A randomised trial comparing chemotherapy regimens with cisplatin (50 mg/m2) versus moderate doses of cisplatin and carboplatin in stage iv non-small cell lung cancer

✍ Sculier, J.P; Lafitte, J.J; Thiriaux, J; Alexopoulos, C.G; Baumöhl, J; Koumakis, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Integrated analysis for two randomized p

Integrated analysis for two randomized phase III studies comparing Taxotere at 75 mg/m2 and 100 mg/m2 to control regimens in non-small cell lung cancer (NSCLC) patients previously treated with a platinum-based chemotherapy

✍ Kim, Y.P; Koch, G; Shepherd, F.A; Fossella, F; Hammershaimb, L; Gamza, F; Rodger 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Phase II study of ASA404 (vadimezan, 5,6

Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800mg/m2 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer

✍ McKeage, Mark J.; Reck, Martin; Jameson, Michael B.; Rosenthal, Mark A.; Gibbs, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 250 KB